1. A feasibility study of a peer discussion group intervention for patients with pancreatobiliary cancer and their caregivers. Issue 4 (August 2022) Authors: Yanai, Yuko; Makihara, Reiko Ando; Matsunaga, Naoko; Shimizu, Rieko; Tominaga, Sayaka; Hoshino, Saki; Nishibuchi, Yukiko; Maruki, Yuta; Ohba, Akihiro; Shimizu, Ken; Okusaka, Takuji Journal: Palliative & supportive care Issue: Volume 20:Issue 4(2022) Page Start: 527 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. A multicenter Phase II study of sorafenib in Japanese patients with advanced hepatocellular carcinoma and Child Pugh A and B class. (21st February 2018) Authors: Suzuki, Eiichiro; Kaneko, Shuichi; Okusaka, Takuji; Ikeda, Masafumi; Yamaguchi, Kensei; Sugimoto, Rie; Aramaki, Takeshi; Asagi, Akinori; Yasui, Kohichiroh; Sano, Keiji; Hosokawa, Ayumu; Kato, Naoya; Ishii, Hiroshi; Sato, Tosiya; Furuse, Junji Journal: Japanese journal of clinical oncology Issue: Volume 48:Number 4(2018) Page Start: 317 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. A National Survey to Systematically Identify Factors Associated With Oncologists' Attitudes Toward End-of-Life Discussions: What Determines Timing of End-of-Life Discussions?. (7th October 2015) Authors: Mori, Masanori; Shimizu, Chikako; Ogawa, Asao; Okusaka, Takuji; Yoshida, Saran; Morita, Tatsuya Journal: Oncologist Issue: Volume 20:Number 11(2015) Page Start: 1304 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. A National Survey to Systematically Identify Factors Associated With Oncologists' Attitudes Toward End‐of‐Life Discussions: What Determines Timing of End‐of‐Life Discussions?. (7th October 2015) Authors: Mori, Masanori; Shimizu, Chikako; Ogawa, Asao; Okusaka, Takuji; Yoshida, Saran; Morita, Tatsuya Journal: Oncologist Issue: Volume 20:Number 11(2015) Page Start: 1304 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. A randomised phase II study of modified FOLFIRINOX versus gemcitabine plus nab-paclitaxel for locally advanced pancreatic cancer (JCOG1407). (March 2023) Authors: Ozaka, Masato; Nakachi, Kohei; Kobayashi, Satoshi; Ohba, Akihiro; Imaoka, Hiroshi; Terashima, Takeshi; Ishii, Hiroshi; Mizusawa, Junki; Katayama, Hiroshi; Kataoka, Tomoko; Okusaka, Takuji; Ikeda, Masafumi; Sasahira, Naoki; Miwa, Haruo; Mizukoshi, Eishiro; Okano, Naohiro; Mizuno, Nobumasa; Yamamot... Journal: European journal of cancer Issue: Volume 181(2023) Page Start: 135 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. A randomized Phase III trial of adjuvant S-1 therapy vs. observation alone in resected biliary tract cancer: Japan Clinical Oncology Group Study (JCOG1202, ASCOT). (15th February 2018) Authors: Nakachi, Kohei; Konishi, Masaru; Ikeda, Masafumi; Mizusawa, Junki; Eba, Junko; Okusaka, Takuji; Ishii, Hiroshi; Fukuda, Haruhiko; Furuse, Junji Journal: Japanese journal of clinical oncology Issue: Volume 48:Number 4(2018) Page Start: 392 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. A randomized, double‐blind, placebo‐controlled, phase 3 study of tivantinib in Japanese patients with MET‐high hepatocellular carcinoma. Issue 10 (26th August 2020) Authors: Kudo, Masatoshi; Morimoto, Manabu; Moriguchi, Michihisa; Izumi, Namiki; Takayama, Tetsuji; Yoshiji, Hitoshi; Hino, Keisuke; Oikawa, Takayoshi; Chiba, Tetsuhiro; Motomura, Kenta; Kato, Junko; Yasuchika, Kentaro; Ido, Akio; Sato, Takashi; Nakashima, Daisuke; Ueshima, Kazuomi; Ikeda, Masafumi; Okusa... Journal: Cancer science Issue: Volume 111:Issue 10(2020) Page Start: 3759 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. A retrospective analysis of factors associated with selection of end-of-life care and actual place of death for patients with cancer. Issue 5 (2nd May 2014) Authors: Kondo, Shunsuke; Shimazu, Taichi; Morizane, Chigusa; Hosoi, Hiroko; Okusaka, Takuji; Ueno, Hideki Journal: BMJ open Issue: Volume 4:Issue 5(2014) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. A review of changes to and clinical implications of the eighth TNM classification of hepatobiliary and pancreatic cancers. (10th December 2019) Authors: Ueno, Makoto; Morizane, Chigusa; Ikeda, Masafumi; Okusaka, Takuji; Ishii, Hiroshi; Furuse, Junji Journal: Japanese journal of clinical oncology Issue: Volume 49:Number 12(2019) Page Start: 1073 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
10. Adjuvant and neoadjuvant therapy for biliary tract cancer: a review of clinical trials. (10th October 2020) Authors: Nara, Satoshi; Esaki, Minoru; Ban, Daisuke; Takamoto, Takeshi; Shimada, Kazuaki; Ioka, Tatsuya; Okusaka, Takuji; Ishii, Hiroshi; Furuse, Junji Journal: Japanese journal of clinical oncology Issue: Volume 50:Number 12(2020) Page Start: 1353 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗